MyMD Pharmaceuticals Inc (MYMD)
2.85
-0.01
(-0.35%)
USD |
NASDAQ |
Apr 25, 11:22
MyMD Pharmaceuticals Total Assets (Quarterly): 17.86M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.86M |
| September 30, 2023 | 21.83M |
| June 30, 2023 | 25.25M |
| March 31, 2023 | 28.41M |
| December 31, 2022 | 17.54M |
| September 30, 2022 | 20.23M |
| June 30, 2022 | 19.16M |
| Date | Value |
|---|---|
| March 31, 2022 | 22.20M |
| December 31, 2021 | 24.81M |
| September 30, 2021 | 28.01M |
| June 30, 2021 | 34.45M |
| March 31, 2021 | 35.80M |
| December 31, 2020 | 0.6767M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.6767M
Minimum
Dec 2020
35.80M
Maximum
Mar 2021
22.79M
Average
22.20M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Acrivon Therapeutics Inc | 138.26M |
| Vincerx Pharma Inc | 18.22M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.493M |
| Shareholders Equity (Quarterly) | 12.37M |